Non-self reporting screening tool for post-traumatic stress disorder (PTSD)

Ended Purchase Order Awarded Last action

Contract number
FA864923P0042
Awardee
Awarding agency
Obligated
$1,249,838

Award facts

Contract value 100% obligated
$1,249,838.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 643 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
North Potomac, MD, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Vendor Address Change P00003 $0
Supplemental Agreement for work within scope P00002 · Sbir phase II proposal F2D-6405 - non-self reporting screening tool for ptsd $0
Vendor Address Change P00001 $0
Original award $1,249,838

About this award

The U.S. Air Force Research Laboratory has awarded a firm-fixed-price SBIR Phase II contract worth $1,249,838.00 to Trugenomix Health, Inc. (doing business as Polaris Genomics) for the development of a non-self-reporting screening tool for post-traumatic stress disorder (PTSD). This contract is set aside for a small business and has a completion date of December 30, 2025.

Quick answers

Who was awarded contract FA864923P0042?

FA864923P0042 was awarded to Trugenomix Health, Inc. by Air Force Research Laboratory (Air Force Materiel Command) on December 21, 2022.

How much is contract FA864923P0042 worth?

The government has obligated $1,249,838 on FA864923P0042.

Was contract FA864923P0042 competed?

The extent of competition for FA864923P0042 was full and open competition after exclusion of sources. The government received 643 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award